Agreement (sensitivity, specificity) with netrin-1 to predict incipient DN
AUC | P value | 95% CI | Cut-off | Sensitivity | Specificity | ||
LL | UL | ||||||
Incipient DN (microalbuminuria) versus T2DM (normoalbuminuria) | |||||||
Serum netrin-1 (pg/mL) | 0.812 | <0.001* | 0.715 | 0.886 | >162 | 60 | 84.4 |
Urinary netrin-1 (pg/mg creatinine) | 0.916 | <0.001* | 0.839 | 0.964 | >720 | 77.8 | 84.4 |
Combined netrin-1 | 0.938 | <0.001* | 0.867 | 0.978 | – | – | – |
Overt DN (macroalbuminuria) versus incipient DN (microalbuminuria) | |||||||
Serum netrin-1 (pg/mL) | 0.939 | <0.001* | 0.868 | 0.978 | >250 | 86.7 | 93.3 |
Urinary netrin-1 (pg/mg creatinine) | 0.931 | <0.001* | 0.857 | 0.973 | >1450 | 80 | 95.6 |
Combined netrin-1 | 0.958 | <0.001* | 0.893 | 0.989 | – | – | – |
Cut-off was chosen according to Youden’s index.
*Significant at p<0.05.
AUC, area under the curve; ;DN, diabetic nephropathy; LL, lower limit; T2DM, type 2 diabetes mellitus; UL, upper limit.